Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene [0.03%]
SERPINC1基因无义突变所致严重静脉血栓栓塞症家系的遗传及临床特征分析
Xuqian Wei,Weibin Chen,Jian Zhang et al.
Xuqian Wei et al.
Antithrombin (AT) III is a key physiological anticoagulant, and its hereditary deficiency represents one of the most severe forms of inherited thrombophilia. However, as a rare disorder, AT III deficiency is frequently underdiagnosed due to...
Efficacy and safety of anticoagulation dose reduction for venous thromboembolism prophylaxis in low body weight patients: a systematic review and meta-analysis [0.03%]
低体重患者静脉血栓栓塞预防的抗凝剂量减少的有效性和安全性：系统评价和meta分析
Ian Gabriel Alparaque Juyad,Rochelle Ivy A Cion,Genquen Philip Carado et al.
Ian Gabriel Alparaque Juyad et al.
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase [0.03%]
卢匹抗凝物和抗心磷脂抗体与稳定期镰形细胞性贫血的血液学参数及临床发现的相关性研究
Mohammed Aw Almorish,Ahmed M E Elkhalifa,Moataz Mohamedalhasan Ali et al.
Mohammed Aw Almorish et al.
Background: Current therapeutic interventions for Sickle Cell Disease (SCD) have improved patient survival; however, the clinical determinants of elevated autoantibody prevalence and related complications in patients with...
Long-term patency of the transjugular intrahepatic portosystemic shunt for portal and superior mesenteric vein thrombosis [0.03%]
经颈静脉肝内门体分流术治疗门静脉和肠系膜上静脉血栓形成的长期通畅性
Junyang Luo,Churen Zhou,Yanyang Zhang et al.
Junyang Luo et al.
A retrospective study on the clinical outcomes of endovascular intervention treatment for inferior vena cava filter thrombosis [0.03%]
下腔静脉滤器血栓置入血管内介入治疗的临床疗效回顾性研究
Shiqiang Liao,Shuming Shi,Chuanyong Li et al.
Shiqiang Liao et al.
Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials [0.03%]
抗凝治疗脓毒症患者的疗效和安全性：随机对照试验的meta分析研究
Qi Wang,JiaYu Wu,WenHao Tang et al.
Qi Wang et al.
Background: Coagulation dysfunction significantly impacts sepsis prognosis. Standardized methods for evaluating anticoagulant efficacy and safety in this population remain lacking. This study aimed to assess the efficacy ...
Molecular diagnosis of inherited platelet disorders: a tale of two realities - advanced vs. resource-limited setting [0.03%]
遗传性血小板疾病分子诊断的双重现实-先进与资源有限环境下比较
Seyed Mehrab Safdari,Sina Jozdani,Mahsa Mottaghizadeh-Jazi et al.
Seyed Mehrab Safdari et al.
Background: Inherited platelet disorders are a heterogeneous group of rare conditions characterized by impaired platelet production or function, often leading to significant bleeding complications. Accurate diagnosis is e...
Clinical features and risk factors for poor prognosis in malignant tumor patients with pulmonary embolism: a case control study [0.03%]
恶性肿瘤患者肺栓塞的临床特点及预后不良的风险因素分析：病例对照研究
Kexin Dong,Hongyuan Kong,Lin Wang et al.
Kexin Dong et al.
Fahad S Alshehri,Abdurahman Alloghbi,Abdulrahman Alshalani et al.
Fahad S Alshehri et al.
Cancer-associated thrombosis (CAT), especially venous thromboembolism (VTE), is the second highest cause of mortality in cancer patients, following the cancer itself. Notably, among patients with thrombosis, cancer is the most common underl...
A nomogram for individualized prediction of calf muscular venous thrombosis in patients with acute ischemic stroke: a retrospective study [0.03%]
急性缺血性卒中患者下肢深静脉血栓形成的个体化预测列线图研究
Li Gao,Jingjing Yao,Yongliang Pan et al.
Li Gao et al.